Driving Factors and Key Players in the Booming Single use Bioreactors Market

-

The global single use bioreactors market is experiencing significant growth and is projected to reach USD 8.8 billion by 2026, showing a substantial increase from USD 3.4 billion in 2021. This growth is primarily driven by various factors contributing to the adoption and utilization of single-use bioreactors (SUBs). Several key drivers and opportunities shape the market landscape.

One of the key drivers of the single-use bioreactors market is the increasing adoption of SUBs among small companies and startups. These entities often face limitations in terms of infrastructure, resources, and capital investment. SUBs provide a cost-effective solution as they eliminate the need for cleaning and sterilization, reducing operational costs and time. The simplified design of SUBs, with fewer components and reduced automation complexity, enables smaller companies to enter the biopharmaceutical manufacturing sector more easily.

Another driver for the market growth is the ease in the cultivation of marine organisms. SUBs offer advantages in the cultivation of marine-based organisms due to their flexibility and ease of use. Marine biotechnology has gained significant attention for various applications, including the production of biologics and therapeutics derived from marine sources. SUBs facilitate the cultivation and scale-up of marine organisms, supporting the expansion of research and development activities in this area.

Furthermore, SUBs contribute to reduced energy and water consumption compared to traditional stainless-steel bioreactors. The streamlined design and disposability of SUBs eliminate the need for extensive cleaning, sterilization, and water-intensive processes. This not only reduces operational costs but also aligns with sustainability goals by conserving resources and minimizing environmental impact.

The growing biologics market is another factor propelling the demand for single-use bioreactors. Biologics, including monoclonal antibodies, vaccines, and cell therapies, have witnessed substantial growth in recent years. SUBs offer advantages in biologics manufacturing by providing a more flexible and cost-effective platform for producing these complex therapeutics. The increasing demand for biologics drives the adoption of SUBs, enabling efficient and scalable production processes.

Technological advancements in SUBs also play a significant role in market growth. Ongoing research and development efforts focus on enhancing SUB performance, such as improving cell culture performance, optimizing mixing and aeration, and developing innovative sensor technologies. These advancements contribute to better process control, higher product yields, and improved efficiency, further driving the adoption of SUBs in biopharmaceutical manufacturing.

In the competitive landscape, prominent players such as Sartorius Stedim Biotech, Thermo Fisher Scientific, Danaher Corporation (through its subsidiary Pall Corporation), and Merck KGaA hold leading positions. Sartorius Stedim Biotech has strengthened its market presence through organic and inorganic strategies, including product launches and expansions. Danaher Corporation, with its subsidiary Pall Corporation, has expanded its market share through acquisitions, such as the acquisition of General Electric Company's Life Sciences division and subsequent rebranding as Cytiva.

Opportunities in emerging markets, such as India, present a significant growth potential for the single-use bioreactors market. The presence of global and local pharmaceutical and biopharmaceutical companies in these countries, coupled with government initiatives and regulatory measures, drives the demand for cost-effective single-use systems. The expansion of manufacturing capacities for COVID-19 vaccines in India, utilizing SUBs, exemplifies the growing trend of implementing SUB technology in emerging markets.

In summary, the global single-use bioreactors market is poised for substantial growth, driven by factors such as the adoption of SUBs by small companies and startups, reduced automation complexity, ease of cultivation for marine organisms, reduced energy and water consumption, the expanding biologics market, technological advancements, and opportunities in emerging markets. With key players actively participating

Related Links

https://www.marketsandmarkets.com/Market-Reports/single-use-bioreactor-market-49113750.html

https://www.marketsandmarkets.com/PressReleases/single-use-bioreactor.asp

https://www.marketsandmarkets.com/ResearchInsight/single-use-bioreactor-market.asp

Comments

Post a Comment

Popular posts from this blog

Future of Remote Patient Monitoring Industry: Impact of Remote Patient Monitoring on Healthcare

-
Remote patient monitoring is a type of telemedicine technology that enables healthcare providers to monitor their patients’ health remotely. This technology utilizes remote devices that are placed in the patient’s home or worn by the patient to collect medical data such as vital signs and other medical information.  This medical data is then transmitted to the doctor or healthcare provider to help them make better decisions regarding the patient’s care. RPM can be used to monitor a variety of conditions including chronic diseases, mental health issues, and post-operative care. It can also be used to support elderly individuals and those with disabilities. RPM has the potential to improve patient outcomes and reduce healthcare costs by enabling healthcare providers to monitor their patients’ health more effectively. Benefits of Remote Patient Monitoring 1. Increased Patient Engagement: Remote patient monitoring systems provide patients with a convenient way to stay engaged in thei...
Read more

Strategies Adopted by the Major Players in this Digital PCR Market

-
 According to research report the  Digital PCR Market  is expected to grow from USD 3.47 billion in 2017 to USD 5.31 billion by 2022, at a CAGR of 8.9% during the forecast period. Product Launches: Key Strategy Adopted by the Major Players in this Market New product launches and approvals are the key growth strategies adopted by major players to strengthen their position in the global Digital PCR Market. Moreover, strategies such as partnerships, collaborations, and agreements; as well as mergers and acquisitions were also adopted by several market players to strengthen their market position, expand their R&D capabilities, and geographic presence in the global Digital PCR Market. The key players in the Digital PCR Market include Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluid...
Read more

Sinus Dilation Devices Market Size And Share Report, 2027

-
The sinus dilation devices market is on track for significant growth in the coming years, projected to reach USD 3.8 billion by 2027, up from USD 2.8 billion in 2022. This represents a compound annual growth rate (CAGR) of 6.6% during the forecast period. The market's expansion is largely driven by the increasing availability of reimbursements and rising cases of chronic sinusitis. However, the market faces challenges due to the availability of non-surgical treatments for chronic sinusitis and a shortage of skilled ENT surgeons. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64349810 Key Market Drivers Increasing Availability of Reimbursements: The growing availability of reimbursements for sinus dilation procedures is making them more accessible to patients, thereby driving demand for sinus dilation devices. Rising Incidence of Chronic Sinusitis: The prevalence of chronic sinusitis is on the rise globally, leading to an increase in d...
Read more